Keywords: millennium, pharmaceuticals, set, buy, leukosite, million, hoping

Millennium Pharmaceuticals set to buy LeukoSite for $635 million

Article | 18 October 1999

Print This

Millennium Pharmaceuticals is hoping to gain access to a stronglate-stage pipeline after agreeing to acquire LeukoSite in a stock deal ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in